We are committed to working with corporate strategic partners, medical organizations and academic institutions to enhance the global reach of our PLX product portfolio. To that end, we place great importance on the collaborative process involved. We recognize that our partners are committed to developing new products in the cell therapy space based on Pluristem’s unique PLX product portfolio and innovative manufacturing capabilities. Understanding that our partners face unique challenges and opportunities, Pluristem strives to work with potential partners and provide them solutions to expand their product pipeline and address their manufacturing needs. One of the benefits of partnering with Pluristem is our dedicated business development team which focuses on ensuring successful partnerships from the start of the relationship.
Pluristem is a partner of choice for global pharmaceutical, biologics and medical device companies. Tailoring our partnerships to the needs of each potential partner allows Pluristem to maximize the potential of each asset in our portfolio. If you are interested in the Pluristem PLX technology platform, please contact us and let’s see what we can achieve together.